Dow Up1.22% Nasdaq Up2.00%

Infinity Pharmaceuticals, Inc. (INFI)

-NasdaqGS
5.16 Up 0.28(5.74%) May 24, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 9,256   9,079   90,743   4,881  
Cost of Revenue -   -   -   -  
Gross Profit 9,256   9,079   90,743   4,881  
Operating Expenses
Research Development39,188  38,889  37,730  34,062  
Selling General and Administrative10,836  9,352  9,753  9,410  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (40,768) (39,162) 43,260   (38,591)
Income from Continuing Operations
Total Other Income/Expenses Net413  137  75  263  
Earnings Before Interest And Taxes(40,355)(39,025)43,335  (38,328)
Interest Expense309  310  311  100  
Income Before Tax(40,664)(39,335)43,024  (38,428)
Income Tax Expense -  (145)480   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(40,664)(39,190)42,544  (38,428)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (40,664) (39,190) 42,544   (38,428)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (40,664) (39,190) 42,544   (38,428)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.